Stimuli-Responsive Nanocarriers: Recent Advances in Tailor-Made Therapeutics
Editat de Virendra Gajbhiye, Kavita Gajbhiye, Seungpyo Hongen Limba Engleză Paperback – 10 ian 2022
Various recent advances and biomedical applications assembled in this book will guide scientists on how to design and develop novel controlled drug release systems.
- Provides comprehensive knowledge of basic design, mechanism and construction of nanocarrier based stimuli-responsive drug releases
- Explores various nanocarriers characteristically used in the development of stimuli-responsive drug release systems
- Envisages future opportunities, challenges and implementation of nanocarrier based stimuli-responsive drug release systems in disease therapeutics
Preț: 945.25 lei
Preț vechi: 1183.31 lei
-20% Nou
Puncte Express: 1418
Preț estimativ în valută:
180.91€ • 188.37$ • 152.88£
180.91€ • 188.37$ • 152.88£
Carte tipărită la comandă
Livrare economică 28 februarie-14 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128244562
ISBN-10: 0128244569
Pagini: 484
Dimensiuni: 191 x 235 mm
Greutate: 0.83 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128244569
Pagini: 484
Dimensiuni: 191 x 235 mm
Greutate: 0.83 kg
Editura: ELSEVIER SCIENCE
Public țintă
Primary: Pharmaceutical researchers and medical personnel involved in the development of advanced techniques and methods for diagnosis and treatment of various diseases. Postgraduate students will also find this useful.Secondary: Biomedical professionals working in drug delivery
Cuprins
1. An overview of stimuli-responsive nanocarriers: State of the art
2. Stimuli responsive strategies: Role of various molecules/moieties facilitating design of stimuli-responsive nanocarriers
3. Vesicular nanocarriers based stimuli-responsive drug delivery systems
4. Stimuli-responsive polymeric nanoparticles as controlled drug delivery system
5. Dendrimers and dendritic nanoparticles for Stimuli-responsive nanomedicine
6. Iron oxide nanocarrier as promising controlled drug delivery vehicle
7. Stimuli-responsive drug delivery systems for immunotherapy
8. Quantum dots based vehicles for controlled drug release in conjunction with bio-imaging
9. Mesoporous silica nanoparticles based stimuli triggered drug release systems
10. Solid lipid nanoparticles based vehicles for stimuli inspired delivery of bioactives
11. Tailored gold nanoparticles for improved controlled over drug release
12. Lipid–polymer hybrid nanoparticles as smart drug delivery platform
13. Polymerosomes as promising vehicle for controlled drug delivery
14. Carbon nanomaterial-based stimuli-responsive drug delivery strategies
15. Protein nanocapsules as a smart drug delivery platform
16. Copper nanoparticles based stimuli-responsive approaches
17. Stimuli-responsive nanogels as promising carriers for controlled delivery of anticancer therapeutics
2. Stimuli responsive strategies: Role of various molecules/moieties facilitating design of stimuli-responsive nanocarriers
3. Vesicular nanocarriers based stimuli-responsive drug delivery systems
4. Stimuli-responsive polymeric nanoparticles as controlled drug delivery system
5. Dendrimers and dendritic nanoparticles for Stimuli-responsive nanomedicine
6. Iron oxide nanocarrier as promising controlled drug delivery vehicle
7. Stimuli-responsive drug delivery systems for immunotherapy
8. Quantum dots based vehicles for controlled drug release in conjunction with bio-imaging
9. Mesoporous silica nanoparticles based stimuli triggered drug release systems
10. Solid lipid nanoparticles based vehicles for stimuli inspired delivery of bioactives
11. Tailored gold nanoparticles for improved controlled over drug release
12. Lipid–polymer hybrid nanoparticles as smart drug delivery platform
13. Polymerosomes as promising vehicle for controlled drug delivery
14. Carbon nanomaterial-based stimuli-responsive drug delivery strategies
15. Protein nanocapsules as a smart drug delivery platform
16. Copper nanoparticles based stimuli-responsive approaches
17. Stimuli-responsive nanogels as promising carriers for controlled delivery of anticancer therapeutics